DBV Technologies S.A. (DBVT) Q4 2023 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Dbv Technologies Sa.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.089 -- 00:00:03.330 Apologies for the late start of our conference. 00:00:03.330 -- 00:00:07.452 Welcome to the DBV full year 2023 00:00:07.452 -- 00:00:11.334 financial results and business update conference call. 00:00:11.334 -- 00:00:14.135 All participants will be in listen-only mode. 00:00:14.135 -- 00:00:18.737 Should you need assistance, please signal a conference specialist by pressing the star 00:00:18.737 -- 00:00:24.540 key followed by zero. After today's presentation, there will be an opportunity 00:00:24.540 -- 00:00:29.890 to ask questions. To ask a question, you may press star, then one on your telephone 00:00:29.890 -- 00:00:34.674 keypad. To withdraw your question, please press star, then two. 00:00:34.674 -- 00:00:39.337 Please note this event is being recorded. I would now like to turn the conference over 00:00:39.337 -- 00:00:42.620 to Katie Matthews, Investor Relations. Please go ahead. 00:00:42.620 -- 00:00:44.620 Thank 00:00:44.881 -- 00:00:48.724 you. And again, our sincere apologies for the delay in starting today. 00:00:48.724 -- 00:00:53.808 This afternoon, BBV Technologies issued a press release that outlines 00:00:53.808 -- 00:00:59.506 our financial results for the 12 months ended December the 31st, 2023. 00:00:59.506 -- 00:01:05.090 This press release is available in the Press Releases section of the DBV Technologies 00:01:05.090 -- 00:01:06.972 website. 00:01:06.972 -- 00:01:11.775 Before we begin, please note that today's call may include a number of forward-looking 00:01:11.775 -- 00:01:17.460 statements, including but not limited to comments regarding our clinical and regulatory 00:01:17.460 -- 00:01:22.998 development plans. The design of our anticipated clinical trials the timing 00:01:22.998 -- 00:01:28.119 and re...